Bioinnovation has the potential to power your business ambition. And we are uniquely placed – with world-class expertise and facilities – to help deliver tangible, valuable commercial advantage.

We innovate at the exciting intersection of biology, engineering and advanced computation… to deliver breakthrough products and services with world-changing significance. Ours is a comprehensive approach founded on three core capabilities – Biostrategy, Biomeasurement and Biomanufacture.

Biostrategy, Biomeasurement and Biomanufacture


Getting to market as the world transforms

Now more than ever, your route to market must navigate a complex, shifting global landscape. As risks arise, so do the potential rewards. Bioinnovation has the rare capacity to provide clarity and momentum in critical areas of opportunity, such as healthcare, agriculture and climate change. 

Ideas are the easier part; making them a reality is harder. The truth is, you require more than good technology to deliver positive change in a commercial context. To get to market, you need robust, realistic strategies. We can help you develop them because we understand the tools (biotechnology), the rules (governance models) and the interests (economic models) involved. Aligning all three is the secret of business success in Bioinnovation.

Gaining insight with better information

Bioinnovation relies absolutely on Biomeasurement. It is the bedrock that enables control and optimisation. But biological systems are extremely complex, span a huge scale range from km to nm and are incredibly difficult to measure. Success relies on seamless integration across numerous disciplines at which we are adept – including wetware, hardware and software. 

Our unique blend of abilities helps you bring new measurement and diagnosis products to market or integrate new measurement tools into your process and catalyse productivity gains. We understand and develop innovative sensors and cutting-edge data analysis. We’re able to bring together molecular biology, assay development, physics, electronics and AI to achieve the most complex measurements. And we package them for you in robust, easy-to-use, cost-effective solutions that comply with stringent regulatory requirements, including cGMP and medical devices.

Scaling up and delivering at viable cost

Researchers are continually discovering new ways to apply biology in their pursuit of breakthrough innovation. The real challenge is moving complex processes from the lab to high-volume manufacture at a cost that delivers business viability. Experience tells us that successful scale up demands optimisation and invention across all disciplines – including biology, hardware, usability and control systems – plus rigorous regulatory compliance. 

We can help you optimise processes and develop the custom equipment you need to deliver at commercial cost and scale. We work seamlessly across biology, process optimisation and equipment design to enable the successful manufacture and delivery of your product or advanced medicinal therapy.

Talk to us about world-changing science 

Our experience 


Proven in biodesign 

Our proven biodesign capability has grown organically from our long history in healthcare and life sciences. Few if any of our peers can match our holistic approach which adds biodesign to the complementary disciplines of engineering and computation. This unique breadth of expertise offers significant advantages that speed and ease your path to biomanufacture.

Antha expertise 

Antha is a programming language for biology. It describes and executes complex workflows, driving massive productivity gains during biodesign. We are long-term partners with Synthace and use Antha in our labs. We can help you discover the power of Antha to unlock your science and gather the data you need without limits.

Meet the core team


"We started with an idea; we’re now working with some of the most innovative biotech companies in the world." Richard Hammond
"Biology knows no bounds and follows different rules to typical engineering tools and materials." Ellen Simmons
"The best part of my job is working every day with engineers and professionals who are at the top of the field. The atmosphere at Cambridge Consultants is one of fun people who love what they do." Mary Karavengleman
“What excites me most is that bioinnovation will affect so many different industries – from the obvious ones like healthcare and agriculture to the more surprising like data storage and plastics.” James Hallinan
"Our clients are diverse, the science they are trying to deliver is novel. Every project brings the opportunity to gain a new understanding." Ian Taylor

Tech, tools & facilities


Synthetic biology lab
 

Synthetic biology labs

Located in our Cambridge head office, our microbiology lab enables us to genetically modify micro-organisms and characterise them. Our facilities are containment level 2 rated for handling pathogenic strains and our in-house libraries allow rapid modular DNA construct design and assembly. We are particularly interested in building organisms that are biological sensors for healthcare and industrial biotech applications.

Life Science Labs
 

Life science labs

Our suite of restricted Class II laboratories are specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.

Cell culture lab
 

Cell culture labs

Our life science and synthetic biology facilities are complemented by our recently established cell culture labs. They support our clients in the advanced therapies and medicinal products field to deliver the most advanced drugs on the planet. We’ve equipped them with tools to monitor, grow and store cells which are relevant to cell and gene therapy process development.

Discover the latest in bioinnovation


Case study

CATALOG DNA data encoding machine

11th May 2020

Enabling the world's first DNA-based platform for massive data storage

  • Synthetic biology
Press release

Rapid discovery and manufacture of next-generation cell therapies

21st Jan 2020

Kytopen engages Cambridge Consultants to co-develop alpha Flowfect™ System 

  • Industrial design
  • Product realisation
  • Synthetic biology
Press release

Harnessing AI to address global health challenges

24th Sep 2019

BacillAi is a concept system using AI and low-cost hardware to improve treatment monitoring of TB in resource-limited countries, part of our mission to move AI beyond the hype, addressing practical, global challenges.

  • Digital health
  • Human factors
  • Mechanical engineering
  • User Experience (UX)
Press release

Cambridge Consultants partners with Hitachi Central Research Laboratory to address the global challenge of plastic waste

18th Sep 2019

Cambridge Consultants joins the Kyōsō-no-Mori Partnership Program and will work with Hitachi to investigate the applications and business models for applying synthetic biology to plastic recycling.

  • Physical sciences
  • Synthetic biology